Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03721276 · ClinicalTrials.gov registry record · NA
Project EQuIP: Empowering Queer Identities in Psychotherapy
A NA study of Sexual Minority Stress, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03721276: Completed NA study of Sexual Minority Stress, sponsored by Yale University.
NCT03721276 is a NA study of Sexual Minority Stress that has completed, run by Yale University. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03721276, a NA study of Sexual Minority Stress, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to develop an evidence-based psychosocial intervention for sexual minority women. This intervention will specifically target the adverse mental and behavioral health outcomes disproportionately experienced by sexual minority women, including depression, suicidality, and alcohol abuse, which are known to be driven by stigma-related stressors associated with their sexual orientation (i.e., minority stress processes).
Primary Outcome
The measure depression in participants, the Center for Epidemiological Studies - Depression Scale (CES-D) will be used. An overall depression score is computed as the sum of the 20 items, with Items 3, 11, 14, and 16 reversed. In cases with internally missing data (items not answered), the sums were computed after imputation of the missing values: # items on scale / # actually answered, multiplied by the sum obtained from the answered items. A higher score indicates more depressive symptomatolog
Conditions Studied
Interventions
- BEHAVIORAL EQuIP (Empowering Queer Identities in Psychotherapy)
Study Locations (1)
New York
- Yale LGBTQ+ Mental Health Initiative - Research Lab - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-07-18 |
| Est. Completion | 2019-07-18 |
| Phase | NA |
What the finished NCT03721276 record still lists
NCT03721276 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Sexual Minority Stress appearing as the primary indexed condition, and to 1 intervention - of which EQuIP (Empowering Queer Identities in Psychotherapy) is the first listed.
NCT03721276 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03721276 about?
NCT03721276 is a clinical study titled "Project EQuIP: Empowering Queer Identities in Psychotherapy". The aim of this study is to develop an evidence-based psychosocial intervention for sexual minority women. This intervention will specifically target the adverse mental and behavioral health outcomes disproportionately experienced by sexual minority women, including depression, suicidality, and alco...
What is the current status of trial NCT03721276?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-07-18. Estimated completion is 2019-07-18.
What conditions does trial NCT03721276 study?
This clinical trial studies the following conditions: Sexual Minority Stress.
What interventions are being tested in trial NCT03721276?
The interventions under investigation include: EQuIP (Empowering Queer Identities in Psychotherapy) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03721276?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03721276 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03721276's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI